ARCHIVES

NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

DCBD Board Votes down, Then Approves Organ Systems PA

November 10, 1989

Sullivan Confirmation Hearing Set For Feb. 1

January 27, 1989

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

Funding Opportunity: DOD Offering 10.5 Million For Lung Cancer Research

May 30, 2014

Device Shortens Time To Make T Cells For Immunotherapy

March 27, 2009

Two Drugs Slow Progress Of Metastatic Prostate Cancer

June 29, 2001